Papillary renal neoplasm with reverse polarity has low frequency of alterations in chromosomes 7, 17, and Y

• Published in: Virchows Archiv : an international journal of pathology 2024-08, Vol.485 (2), p.299-306
• Main Authors: Kiyozawa, Daisuke, Iwasaki, Takeshi, Takamatsu, Dai, Kohashi, Kenichi, Miyamoto, Takumi, Fukuchi, Genshiro, Eto, Masatoshi, Yamashita, Michifumi, Oda, Yoshinao
• Format: Article
• Language: English
• Subjects: Abnormalities; Chromosome 7; Chromosome aberrations; Chromosomes; Copy number; Fluorescence in situ hybridization; Genomic analysis; Hybridization; Immunohistochemistry; Medicine; Medicine & Public Health; Neoplasia; Nuclei; Original Article; Pathology; Trisomy; Tumorigenesis; Tumors
• ISSN: 0945-6317; 1432-2307; 1432-2307
• DOI: 10.1007/s00428-024-03840-6

In papillary renal neoplasm with reverse polarity (PRNRP), the status of chromosomal copy number alterations, especially chromosomes 7/17 gain and chromosome Y loss, has remained controversial. In the literatures, there is a discrepancy among the results of chromosomal alteration in PRNRP depending on the analytical methods. Here, we comprehensively analyzed the status of chromosomal abnormalities in PRNRP. Nineteen PRNRP cases were analyzed by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), five of which were additionally subjected to array-based comparative genomic hybridization (aCGH) analysis. Fifteen cases of PRCC were used as controls. From the aCGH results, no genome copy number abnormalities were found in the five PRNRP cases. By FISH, numbers of nuclei with abnormal chromosomal signals in PRNRP (centromere 7 gain: 11–21% of nuclei, centromere 17 gain: 11% of nuclei, centromere Y loss: 14–31% of nuclei) were similar to those in non-neoplastic tubular cells (centromere 7 gain: 11–15% of nuclei, centromere 17 gain: 12–15% of nuclei, centromere Y loss: 13–45% of nuclei). c-MET immunohistochemical overexpression, a substitute marker for chromosome 7 trisomy, was observed in 0 of 19 PRNRP cases, consistent with the analyses by aCGH and NGS regarding chromosome 7 gain. Taken together, the frequency of chromosomal alterations in PRNRP is similar to that in non-neoplastic tubular cells, and lower than that in PRCC. Our data suggest that PRNRP has a different tumorigenesis and is a distinct entity from PRCC.